Related Experiment Video
Updated: Jul 17, 2026
11:20
Comparative in vivo Study of gp96 Adjuvanticity in the Frog Xenopus laevis
Published on: September 16, 2010
Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase
Xenotransplantation
|March 7, 2000
Summary
Green coffee bean alpha-galactosidase enzyme removes pig cell antigens, delaying hyperacute rejection in primate transplants. However, its temporary effect limits its clinical value for organ survival.
Area of Science:
- Xenotransplantation immunology
- Enzyme biochemistry
Background:
- Primate antibodies target pig endothelial cells via alpha-galactose (alphaGal) antigens.
- Hyperacute rejection is a major barrier in xenotransplantation.
Purpose of the Study:
- To evaluate the efficacy of green coffee bean alpha-galactosidase in preventing hyperacute rejection.
- To determine the functional conditions and biochemical effects of the enzyme.
Main Methods:
- In vitro and in vivo studies using pig-to-monkey vein transplants.
- Analysis included light microscopy, SEM, and immunostaining for alphaGal epitopes, IgM, IgG, and C3.
- Enzyme activity was tested at various temperatures and pH levels.
Main Results:
- Alpha-galactosidase removed alphaGal epitopes from pig cells and veins within 30 minutes.
- Enzyme was stable and functional under conditions mimicking human liver graft storage.
- Enzyme treatment significantly delayed hyperacute rejection onset in pig vein grafts (2.5h vs 0.23h).
- Reduced IgM and C3 deposition observed in treated grafts, but endothelial damage occurred within 2 hours.
Conclusions:
- Green coffee bean alpha-galactosidase effectively removes alphaGal antigens and delays hyperacute rejection.
- The enzyme's temporary effect and associated endothelial damage limit its standalone clinical utility for prolonging xenograft survival.
